EACH week, members of the UK’s watchdog Medicines and Healthcare products Regulatory Agency publish their Yellow Card update on adverse reactions to the Covid vaccine.
Every time they do so, they repeat this claim: ‘Vaccination is the single most effective way to reduce deaths and severe illness from Covid-19.’
But how do they know?
The fact is as long as treatments such hydroxychloroquine and ivermectin continue to be banned in the UK, we are prevented from knowing whether treatment could be more effective than vaccines in preventing deaths and reducing severe illness. Published research indicates it could be.
Furthermore without a proper investigation into the thousands of hospital Covid fatalities, how can we know whether the chosen treatment protocols have not been as responsible a cause of death as the disease itself?
In the US, the National Institutes of Health treatment protocol guidance for Covid is based on two drugs, dexamethasone and remdesivir.
Yet at least one major study has called remdesivir into question. Published almost exactly a year ago, it found kidney disorders to be a serious adverse reaction of the drug in coronavirus disease.
It reported that compared with the use of chloroquine, dexamethasone, sarilumab, or tocilizumab, the use of remdesivir was associated with an increased reporting of kidney disorders.
The research states that ‘in the vast majority of cases (316 – 96.6 per cent), no other drug was suspected in the onset of kidney disorders. Reactions were serious in 301 cases (92 per cent) cases, with a fatal outcome for 15 patients (4.6 per cent).
The NHS ‘guidance pathways’ for severe Covid cases – which cover respiratory support to end of life support – are set out here. Other guidance states that ‘treatment with remdesivir may be considered in certain hospitalised patients with Covid‑19 pneumonia’.
Clinicians can also ‘offer dexamethasone to patients with Covid‑19 who need supplemental oxygen, or who have a level of hypoxia (lack of oxygen) that requires supplemental oxygen but are unable to have or tolerate it. If dexamethasone is unsuitable or unavailable, either hydrocortisone or prednisolone can be used’ .
An Oxford Recovery Trial for hospitalised Covid patients found ‘the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomisation but not among those receiving no respiratory support’ .
The perceived limitations of the data are set out here. But for all the glowing testimonials, the survival of the patients in the trial groups – a 22.9 per cent death rate – was not a huge improvement on that in the usual care group, 25.7 per cent
‘Overall, 482 patients (22.9 per cent) in the dexamethasone group and 1,110 patients (25.7 per cent) in the usual care group died within 28 days after randomisation (age-adjusted rate ratio, 0.83; 95 per cent confidence interval [CI], 0.75 to 0.93; P<0.001).’
What this drug treatment was not compared with was the efficacy of either hydroxychloroquine or ivermectin, two successful early intervention treatments that perversely remain banned here.
Sadly we will never know how many lives would have been saved had these drugs been introduced into community and hospital protocols a year ago? I rest my case.
Is isn’t it high time the MHRA revised its claim to say: ‘Vaccine is the single most effective way to reduce deaths and severe illness from Covid-19 in the absence of potentially effective treatments which are banned in the UK.’
Below is the latest full Yellow Card adverse reaction breakdown. It follows a week marked by another seven deaths and a further 82 adverse reactions reported for children, all of which continue to go unremarked by the mainstream media.
MHRA Yellow Card reporting summary up to February 9, 2022 (Data published February 17, 2022)
Adult – primary and booster/third dose, child administration.
* Pfizer: 25.9million people, 49million doses. Yellow Card reporting rate, one in 157 people impacted.
* Astrazeneca: 24.9million people, 49.1million doses. Yellow Card reporting rate, one in 102 people impacted.
* Moderna: 1.6million people, three million doses. Yellow Card reporting rate, one in 45 people impacted.
Overall, one in 118 people injected experienced a Yellow Card adverse event, which may be less than ten per cent of actual figures, according to the MHRA.
The MHRA states that:
* Vaccination is the single most effective way to reduce deaths and severe illness from Covid-19.
* The expected benefits of the vaccines in preventing Covid-19 and serious complications associated with Covid-19 far outweigh any currently known side-effects in the majority of patients.
Adult booster or third doses given = 37,650,239.
Booster Yellow Card reports: 28,941 (Pfizer) + 466 (AZ) + 15,870 (Moderna) + 151 (Unknown) = 45,428.
Reactions: 472,956 (Pfizer) + 862,394 (AZ) + 118,425 (Moderna) + 4653 (Unknown) = 1,458,428.
Reports: 164,679 (Pfizer) + 243,491 (AZ) + 35,566 (Moderna) + 1520 (Unknown) = 445,256 people impacted.
Fatal: 718 (Pfizer) + 1,221 (AZ) + 38 (Moderna) + 40 (Unknown) = 2,017.
Blood disorders: 16,759 (Pfizer) + 7793 (AZ) + 2428 (Moderna) + 62 (Unknown) = 27,042.
Anaphylaxis: 649 (Pfizer) + 871 (AZ) + 87 (Moderna) + 2 (Unknown) = 1,609.
Pulmonary embolism and deep vein thrombosis: 875 (Pfizer) + 3,029 (AZ) + 106 (Moderna) + 25 (Unknown) = 4,035.
Acute cardiac: 12,273 (Pfizer) + 11,147 (AZ) + 3,009 (Moderna) + 90 (Unknown) = 26,519.
Eye disorders: 7,772 (Pfizer) + 14,797 (AZ) + 1,460 (Moderna) + 83 (Unknown) = 24,112
Blindness: 155 (Pfizer) + 317 (AZ) + 31 (Moderna) + 4 (Unknown) = 507.
Deafness: 288 (Pfizer) + 424 (AZ) + 50 (Moderna) + 5 (Unknown) = 767.
Spontaneous abortions: 471 + 1 premature baby death / 15 stillbirth/foetal deaths (11 recorded as fatal) (Pfizer) + 229 + 5 stillbirth (AZ) + 60 + 1 stillbirth (Moderna) + 5 (Unknown) = 765 miscarriages
Nervous system disorders: 78,872 (Pfizer) + 182,030 (AZ) + 19,215 (Moderna) + 839 (Unknown) = 280,956.
Seizures: 1,068 (Pfizer) + 2,050 (AZ) + 250 (Moderna) + 17 (Unknown) = 3,385.
Paralysis: 495 (Pfizer) + 871 (AZ) + 98 (Moderna) + 8 (Unknown) = 1,472.
Tremor: 2,117 (Pfizer) + 9,925 (AZ) + 637 (Moderna) + 50 (Unknown) = 12,729.
Vertigo and tinnitus: 4,078 (Pfizer) + 6,897 (AZ) + 684 (Moderna) + 39 (Unknown) = 11,698
Transverse myelitis: 34 (Pfizer) + 116 (AZ) + 2 (Moderna) = 152
BCG scar reactivation: 67 (Pfizer) + 38 (AZ) + 51 (Moderna) = 156
Headaches and migraines: 35,041 (Pfizer) + 93,844 (AZ) + 9,112 (Moderna) + 331 (Unknown) = 138,328
Vomiting: 5,134 (Pfizer) + 11,631 (AZ) + 1,727 (Moderna) + 59 (Unknown) = 18,551
Infections: 11,611 (Pfizer) + 20,089 (AZ) + 2,160 (Moderna) + 150 (Unknown) = 34,010.
Herpes: 2,149 (Pfizer) + 2,676 (AZ) + 240 (Moderna) + 23 (Unknown) = 5,088.
Immune system disorders: 2,369 (Pfizer) + 3,274 (AZ) + 593 (Moderna) + 21 (Unknown) = 6,257.
Skin disorders: 33,094 (Pfizer) + 53,154 (AZ) + 12,637 (Moderna) + 330 (Unknown) = 99,215.
Respiratory disorders: 20,950 (Pfizer) + 29,585 (AZ) + 4,015 (Moderna) + 196 (Unknown) = 54,746.
Epistaxis (nosebleeds): 1,063 (Pfizer) + 2302 (AZ) + 188 (Moderna) + 11 (Unknown) = 3,564.
Psychiatric disorders: 9,876 (Pfizer) + 18,289 (AZ) + 2,339 (Moderna) + 108 (Unknown) = 30,612.
Reproductive/breast disorders: 30,236 (Pfizer) + 20,649 (AZ) + 4,905 (Moderna) + 199 (Unknown) = 55,989
Children and young people special report – suspected side-effects reported in under-18s:
* Pfizer: 3,200,000 children (first doses) plus 1,500,000 second doses, resulting in 3,044 Yellow Cards.
* AZ: 12,400 children (first doses) resulting in 254 Yellow Cards. Reporting rate one in 49.
* Moderna: 2,000 children (first doses) resulting in 18 Yellow Cards.
* Brand unspecified: 18 Yellow Cards.
Total = 3,214,400 children injected
Total Yellow Cards for under-18s = 3,334
The MHRA states that all children aged five to 11 will be eligible for vaccination in the coming weeks.
For full reports, including 347 pages of specific reaction listings, see here.